PBK and ovarian carcinoma: To determine whether PBK expression was involved in the sensitivity of ovarian cancer cells to PARPi, SKOV3, and UWB1.289 cells with PBK knockdown or overexpression were constructed and challenged with gradient concentrations of olaparib for 72 h (Fig. 1a).